Christian Thomas Ruff, MD, MPH

All posts by Christian Thomas Ruff, MD, MPH

November 26th, 2013

Edoxaban and the Changing Landscape of Novel Anticoagulants for Atrial Fibrillation

Christian Thomas Ruff, a coauthor of the ENGAGE AF-TIMI 48 trial of edoxaban versus warfarin in patients with atrial fibrillation, discusses the future of novel anticoagulants.

January 17th, 2013

Revisiting Novel Anticoagulants in Atrial Fibrillation


Two experts discuss the evolving landscape of novel anticoagulants for patients with AF. Do you agree with their perspectives? What questions do you have? What has your experience taught you?

November 28th, 2011

Roundtable: Two Trials, Two Anticoagulants, Many Implications

, and

Three experts weigh in on findings from the ATLAS ACS 2-TIMI 51 and ADOPT trials.